As an industry leader in recombinant viral vectors (lentivirus, adenovirus, and AAV), abm has 15+ years of experience in how to enhance virus vector transduction efficiency. Over the years, we have developed multiple formulations of viral enhancing agents useful for this purpose. A remarkable breakthrough by our top scientists in 2020 is the development of the most efficient viral enhancing agent, ViralEntry, that is not only effective in enhancing both lentiviral and AAV vector transduction efficiency significantly, but also increases transduction efficiency in diverse cell types including primary T lymphocytes by over 10X. This is superior to any similar product on the market.